Mosquito-borne disease vaccine (AGS-v)
Nearly 700 million people contract mosquito-borne illnesses every year, and over one million people die from them. […]
Universal influenza vaccine (FLU-v)
FLU-v is comprised of four synthetic peptides predicted in silico to cover heavily conserved immunogenic regions of influenza A and B viral proteins M1, M2 and NP-A and NP-B. These internal viral proteins evolve more slowly than the surface proteins traditionally targeted by classical influenza vaccines, which require updating every year. […]